These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
193 related items for PubMed ID: 29477356
1. Simultaneous controlled iontophoretic delivery of pramipexole and rasagiline in vitro and in vivo: Transdermal polypharmacy to treat Parkinson's disease. Kalaria DR, Singhal M, Patravale V, Merino V, Kalia YN. Eur J Pharm Biopharm; 2018 Jun; 127():204-212. PubMed ID: 29477356 [Abstract] [Full Text] [Related]
2. Controlled iontophoretic delivery of pramipexole: electrotransport kinetics in vitro and in vivo. Kalaria DR, Patel P, Merino V, Patravale VB, Kalia YN. Eur J Pharm Biopharm; 2014 Sep; 88(1):56-63. PubMed ID: 24525072 [Abstract] [Full Text] [Related]
6. Controlled iontophoretic transport of huperzine A across skin in vitro and in vivo: effect of delivery conditions and comparison of pharmacokinetic models. Kalaria DR, Patel P, Merino V, Patravale VB, Kalia YN. Mol Pharm; 2013 Nov 04; 10(11):4322-9. PubMed ID: 24028565 [Abstract] [Full Text] [Related]
7. Transdermal delivery of cytochrome C--A 12.4 kDa protein--across intact skin by constant-current iontophoresis. Cázares-Delgadillo J, Naik A, Ganem-Rondero A, Quintanar-Guerrero D, Kalia YN. Pharm Res; 2007 Jul 04; 24(7):1360-8. PubMed ID: 17457661 [Abstract] [Full Text] [Related]
8. Using transdermal iontophoresis to increase granisetron delivery across skin in vitro and in vivo: effect of experimental conditions and a comparison with other enhancement strategies. Cázares-Delgadillo J, Ganem-Rondero A, Quintanar-Guerrero D, López-Castellano AC, Merino V, Kalia YN. Eur J Pharm Sci; 2010 Mar 18; 39(5):387-93. PubMed ID: 20096354 [Abstract] [Full Text] [Related]
9. Understanding the poor iontophoretic transport of lysozyme across the skin: when high charge and high electrophoretic mobility are not enough. Dubey S, Kalia YN. J Control Release; 2014 Jun 10; 183():35-42. PubMed ID: 24657950 [Abstract] [Full Text] [Related]
10. Non-invasive iontophoretic delivery of enzymatically active ribonuclease A (13.6 kDa) across intact porcine and human skins. Dubey S, Kalia YN. J Control Release; 2010 Aug 03; 145(3):203-9. PubMed ID: 20423719 [Abstract] [Full Text] [Related]
13. Controlled Iontophoretic Delivery in Vitro and in Vivo of ARN14140-A Multitarget Compound for Alzheimer's Disease. Singhal M, Merino V, Rosini M, Cavalli A, Kalia YN. Mol Pharm; 2019 Aug 05; 16(8):3460-3468. PubMed ID: 31241959 [Abstract] [Full Text] [Related]
17. Transdermal iontophoretic delivery of terbinafine hydrochloride: quantitation of drug levels in stratum corneum and underlying skin. Sachdeva V, Siddoju S, Yu YY, Kim HD, Friden PM, Banga AK. Int J Pharm; 2010 Mar 30; 388(1-2):24-31. PubMed ID: 20025950 [Abstract] [Full Text] [Related]
18. Transdermal iontophoretic delivery of tacrine hydrochloride: Correlation between in vitro permeation and in vivo performance in rats. Patel N, Jain S, Lin S. Int J Pharm; 2016 Nov 20; 513(1-2):393-403. PubMed ID: 27633278 [Abstract] [Full Text] [Related]